BR102022025291A2
(https= )
2023-08-22
CL2025003930A1
(es )
2026-03-13
Derivados de 3-[3-amino-6-(2-hidroxifenil)piridazin-4-il]-3,8-diazabiciclo[3.2.1]octano como protacs degradadores de smarca2 para el tratamiento del cáncer.
BR102023008688A2
(https= )
2023-06-20
BR102023007252A2
(https= )
2023-06-06
BR102023005164A2
(https= )
2023-05-23
BR102023001877A2
(https= )
2023-06-20
BR102023000289A2
(https= )
2023-07-04
BR102022026909A2
(https= )
2023-06-20
BR102022023461A2
(https= )
2023-07-25
BR202022009269U2
(https= )
2022-11-29
BY13163U
(https= )
2023-04-30
BY13151U
(https= )
2023-04-30
BY23963C1
(https= )
2023-04-30
BY13162U
(https= )
2023-04-30
BY13165U
(https= )
2023-04-30
BY13161U
(https= )
2023-04-30
BY13160U
(https= )
2023-04-30
BY13149U
(https= )
2023-04-30
BY13159U
(https= )
2023-04-30
BY13158U
(https= )
2023-04-30
BY13157U
(https= )
2023-04-30
CN307045614S
(https= )
2022-01-04
BY13156U
(https= )
2023-04-30
CN307045609S
(https= )
2022-01-04
BY13155U
(https= )
2023-04-30